|
PIK3CB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.377600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.627200E-04 |
| Normal-vs-Stage2 |
3.614200E-02 |
| Normal-vs-Stage3 |
7.039500E-03 |
| Normal-vs-Stage4 |
3.717200E-01 |
| Stage1-vs-Stage2 |
9.061400E-01 |
| Stage1-vs-Stage3 |
4.252200E-01 |
| Stage1-vs-Stage4 |
3.590000E-01 |
| Stage2-vs-Stage3 |
6.151600E-01 |
| Stage2-vs-Stage4 |
3.582200E-01 |
| Stage3-vs-Stage4 |
3.542000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.013400E-01 |
| Normal-vs-AfricanAmerican |
8.736700E-03 |
| Normal-vs-Asian |
5.675800E-03 |
| Caucasian-vs-AfricanAmerican |
3.167400E-01 |
| Caucasian-vs-Asian |
1.985400E-01 |
| AfricanAmerican-vs-Asian |
4.454400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.417200E-01 |
| Normal-vs-Female |
4.860100E-02 |
| Male-vs-Female |
4.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.835400E-04 |
| Normal-vs-Extreme_Weight |
1.216650E-04 |
| Normal-vs-Obese |
1.118160E-02 |
| Normal-vs-Extreme_Obese |
1.880970E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.408000E-01 |
| Normal_Weight-vs-Obese |
1.529030E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.102000E-01 |
| Extreme_Weight-vs-Obese |
2.380600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.761600E-01 |
| Obese-vs-Extreme_Obese |
6.648400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.902300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.224600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.156920E-04 |
| Normal-vs-Age(81-100Yrs) |
2.799300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.624200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.314400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.125000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.569400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.407600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.056600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.009700E-02 |
| Normal-VS-Type2 PRCC |
4.663000E-01 |
| Normal-VS-KIRP CIMP |
5.97439999999727E-05 |
| Normal-VS-Unclassified PRCC |
3.417600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.032800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.064100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.963600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.935400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.173000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.775700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.308800E-01 |
| Normal-vs-N1 |
4.503800E-02 |
| Normal-vs-N2 |
2.13739999999074E-05 |
| N0-vs-N1 |
3.565800E-01 |
| N0-vs-N2 |
2.445600E-01 |
| N1-vs-N2 |
1.161830E-01 |
|
|
